Product Certification&
    Enterprise Certification

  • Mr.Xie
    Tel: +86-592-5853819

  • Ms.Serein Yan
    Region Sales Manager
    Tel: +86 0592 5887162

  • Ms.Coco Lv
    Region Sales Manager
    Tel: 0086-592-5881075

  • Ms.Penny Pan
    Region Sales Manager
    Tel: 0086-592-5881087

  • Ms.Shirley Shi
    Region Sales Manager
    Tel: +8613666090822

  • Ms.Denise Lai
    Region Sales Manager
    Tel: 0086-592-5887167

  • Mr.Duncan Deng
    Region Sales Manager
    Tel: +8617750663255

  • Ms.Susie Yan
    Region Sales Manager
    Tel: +8618060975837

  • Ms.Annette Wang
    Region Sales Manager
    Tel: +8615882299465

  • Mobile:+86 13806035118
  • Tel:+86-592-5853819
  • Fax:+86-592-5854960
  • URL:http://www.china-sinoway.com
  • Province/state:fujian
  • City:Xiamen
  • Street:16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China
  • MaxCard:
Home > Products >  99% up Linaclotide powder

99% up Linaclotide powder CAS NO.851199-59-2

  • Min.Order: 25 Kilogram
  • Payment Terms: L/C,D/A,D/P,T/T
  • Product Details

Keywords

  • Linaclotide
  • Linaclotide powder
  • 851199-59-2

Quick Details

  • ProName: 99% up Linaclotide powder
  • CasNo: 851199-59-2
  • Molecular Formula: C59h79n15o21s6
  • Appearance: White powder
  • Application: API
  • DeliveryTime: in 7 days after your payment
  • PackAge: 1kg/bag ;25kg/drum
  • Port: Shanghai/Beijing/Hangzhou
  • ProductionCapacity: 50 Metric Ton/Month
  • Purity: 99% up
  • Storage: Dry place
  • Transportation: cool&dry
  • LimitNum: 25 Kilogram

Superiority

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier . 

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

 

Details

Linaclotide is a once-daily, orally administered, first-in-class agonist of guanylate cyclase-C that is minimally absorbed. It is being developed to treat gastrointestinal disorders. Linaclotide has received its first global approval in the US for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC), and a marketing submission has been filed in the EU for IBS-C. This article summarizes the milestones in the development of linaclotide leading to this first approval for IBS-C and CIC.

Contents of testing      

 

Specifications

Appearance

White or almost white crystalline powder

Identity by HPLC

The reaction is same with the reference substance

Amino Acid Composition

±20% of theoretical

Purity (HPLC)

≥ 98.0%

Related Substance(By HPLC)

Total Impurities(%)≤ 2.0%

Largest Single Impurity(%)≤ 1.0%

Acetate Content(By HPLC)

≤15%

Water Content(By HPLC)

≤5.0%

Bacterial Endotoxins

≤5IU/mg

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog